ARTICLE | Company News
Viragen and Cryolife cancer deal
March 1, 2000 8:00 AM UTC
VRGN and Viragen Europe (VERPC, Plantation, Fla.) will collaborate with CRY on developing cancer therapeutics using CRY's reversible enzyme inhibitor technology. The companies will assess the feasibil...